News about Manufacturing

Lupin Limited Receives USFDA EIR for Goa Manufacturing Facility

Lupin Limited has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration for its manufacturing facility in Goa. The report follows a recent inspection of the site and marks the formal closure of the regulatory review process.

Manufacturing | 01/03/2026 | By Darshana |  239

Indoco Remedies Secures US FDA Approval for Generic Brivaracetam Oral Solution

Indoco Remedies receives US FDA approval to market generic brivaracetam oral solution for partial-onset seizures in the US market.

Manufacturing | 24/02/2026 | By News Bureau |  187

UK Medicines Manufacturing Faces Acute Skills Gap; VR Training Boosts Competency by 40 percent

Advanced medicines manufacturing in the UK is grappling with a significant skills shortage, with too few young professionals entering the sector, according to Ivan Wall, Professor of Regenerative Medicine at University of Birmingham and co-director of RESILIENCE: UK Medicines Manufacturing Skills Centre of Excellence.

Manufacturing | 24/02/2026 | By Darshana |  149

Johnson & Johnson to Invest Over $1 Billion in Pennsylvania Cell Therapy Manufacturing Facility

Johnson & Johnson (JNJ) has announced an investment of more than $1 billion to build a next-generation cell therapy manufacturing facility in Montgomery County, Pennsylvania.

Manufacturing | 20/02/2026 | By Darshana |  163

Lilly Positions India as Global Manufacturing Hub Amid Mounjaro Demand

Eli Lilly and Company is moving to position India as a strategic global manufacturing and export hub, supported by strong demand for its blockbuster diabetes and obesity therapy Mounjaro. A senior executive said the company is advancing plans to integrate India more deeply into its worldwide supply chain through contract manufacturing partnerships.

Manufacturing | 18/02/2026 | By Darshana |  345

Dewpoint Therapeutics Inc advances MYC small molecule toward oncology development manufacturing

Dewpoint Therapeutics Inc., a biotechnology company developing condensate-modulating medicines, has selected a development candidate for its MYC oncology programme, marking a key step toward advancing a first-in-class small molecule designed to regulate MYC-driven cancer biology.

Manufacturing | 15/02/2026 | By Darshana |  174

OXB Signs Multi-Year Commercial Supply Deal with Bristol Myers Squibb

Oxford Biomedica will serve as the commercial manufacturer of lentiviral vectors for Bristol Myers Squibb’s CAR-T programmes under a new multi-year supply agreement, which includes a five-year initial term with an option to extend.

Manufacturing | 05/02/2026 | By News Bureau |  307

Telangana Cracks Down on Illegal Medical Device Manufacturing in Ranga Reddy

The Drugs Control Administration (DCA) of Telangana has uncovered an unlicensed medical device manufacturing and distribution operation in the Ranga Reddy district, leading to the seizure of products and supporting materials valued at Rs 4 lakh.

Manufacturing | 05/02/2026 | By Darshana |  218

FDA Launches PreCheck Pilot to Strengthen Domestic Drug Manufacturing

The USA Food and Drug Administration (FDA) has launched a new pilot initiative aimed at strengthening domestic drug manufacturing and reinforcing the country’s pharmaceutical supply chain.

Manufacturing | 03/02/2026 | By Darshana |  213

Piramal Pharma Acquires Global Rights to Kenalog Brand in Up to USD 100 Million Deal

Piramal Pharma has agreed to acquire the global rights to the Kenalog brand and its associated injectable corticosteroid products from Bristol-Myers Squibb in a deal valued at up to USD 100 million. The acquisition will be executed through Piramal’s wholly owned subsidiary, Piramal Critical Care B.V.

Manufacturing | 02/02/2026 | By Darshana |  565